Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

Helen Dakin; S  Wordsworth; Chris Rogers; G  abangma; J  Raferty; Simon P Harding; Andrew J Lotery; S M Downes; Usha Chakravarthy; Barnaby Reeves

doi:10.1136/bmjopen-2014-005094

Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

Helen Dakin, S Wordsworth , Chris Rogers, G abangma, J Raferty , Simon P Harding, Andrew J Lotery, S M Downes, Usha Chakravarthy, Barnaby Reeves

Bristol Medical School (THS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

62 Citations (Scopus)

Original language	English
Article number	e005094
Journal	BMJ Open
Volume	4
DOIs	https://doi.org/10.1136/bmjopen-2014-005094
Publication status	Published - 29 Jul 2014

Research Groups and Themes

BTC (Bristol Trials Centre)
Centre for Surgical Research

Access to Document

10.1136/bmjopen-2014-005094

Handle.net

Persistent link

ConDuCT-II
Blazeby, J. (Principal Investigator)
1/04/14 → 31/03/19
Project: Research

Emeritus Professor Barnaby C Reeves
- Barney.Reevesbristol.acuk
- Bristol Medical School (PHS) - Emeritus Professor
Person: Honorary and Visiting Academic

Cite this

@article{095b712e98524659b4c4635849731658,

title = "Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial",

author = "Helen Dakin and S Wordsworth and Chris Rogers and G abangma and J Raferty and Harding, \{Simon P\} and Lotery, \{Andrew J\} and Downes, \{S M\} and Usha Chakravarthy and Barnaby Reeves",

year = "2014",

month = jul,

day = "29",

doi = "10.1136/bmjopen-2014-005094",

language = "English",

volume = "4",

journal = "BMJ Open",

issn = "2044-6055",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

AU - Dakin, Helen

AU - Wordsworth , S

AU - Rogers, Chris

AU - abangma, G

AU - Raferty , J

AU - Harding, Simon P

AU - Lotery, Andrew J

AU - Downes, S M

AU - Chakravarthy, Usha

AU - Reeves, Barnaby

PY - 2014/7/29

Y1 - 2014/7/29

U2 - 10.1136/bmjopen-2014-005094

DO - 10.1136/bmjopen-2014-005094

M3 - Article (Academic Journal)

C2 - 25079928

SN - 2044-6055

VL - 4

JO - BMJ Open

JF - BMJ Open

M1 - e005094

ER -

Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

Research Groups and Themes

Access to Document

Handle.net

Projects

ConDuCT-II

Profiles

Emeritus Professor Barnaby C Reeves

Cite this